Tennessee Biotechnology Association | Membership

Atlanta Catheter Therapies, Inc.
Paul Fitzpatrick
770/321-8439
(f):770/321-8871
pfitzpatrick@atlcath.com

58 Edgewood Ave., NE, Suite 113
Atlanta, GA 30303

Company Description:
Atlanta Catheter Therapies, Inc. (ACT) is an early stage research and development medical device company with an innovative and targeted portfolio of catheter technologies for the treatment of vascular disease and restenosis. ACT has developed a revolutionary drug delivery device for the treatment of restenosis (re-blockage of blood vessels) and is developing devices for endovascular debulking (clearing of blocked blood vessels). Investors — ACT is currently seeking Round A funding. Please contact us for a comprehensive executive brief.

www.atlcath.com

Membership Directory

Board of Directors

Academic Chapter

This website managed by Iostudio